Clinical trial
Precision-Based Genomics in Prostate Cancer
NCT04706663
Study timeline
Study start (actual)2021-09-14Date precision: day
Registry last updated2026-09-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
New YorkNew York, United States3BostonMassachusetts, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1PortlandOregon, United States1Ann ArborMichigan, United States1BethesdaMaryland, United States1La JollaCalifornia, United States1EvanstonIllinois, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04706663 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.